What does data on adverse reactions reveal about benzodiazepines and suicide-related risk?: A disproportionality analysis using FDA FAERS pharmacovigilance data
Authors
Discussion
Loading...
Member takes
Implication
Disproportionality analysis reveals varied suicide-related risks among benzodiazepines, indicating heightened monitoring is necessary.
Key Points
- BZDs show significantly elevated risks for suicidal behavior compared to zolpidem, especially flurazepam and alprazolam.
- Among 52,767 psychiatric disorder AEs, 9,474 (about 18%) involved suicidal/self-injurious behavior, highlighting concern over BZDs.
- Disproportionality analysis identified risks in females and younger adults for specific benzodiazepines, suggesting the need for tailored evaluations.
- Research underscores the importance of monitoring certain BZDs due to their association with increased suicide-related risk.
Cite This Study
Guo et al. (2025) studied this question.